Chinese drugs for Shen-tonification could impact the expression of transcription factors in the hypothalamus of aged rats, dominantly on the neuro-endocrine factors responsible for the growth and development. The effects of drugs for tonifying Shen-yang and for tonifying Shen-yin are different, which is probably one of the pharmacological mechanisms of the Shen-tonifying drugs.
Losartan inhibits hyposmotic-induced increase of I Ks current and shortening of action potential duration in guinea pig atrial myocytes Objective: The present study aims to investigate the effect of losartan, an selective angiotensin II type 1 receptor (AT 1 R) blocker, on both the increase of I Ks current and shortening of action potential duration (APD) induced by stretch of atrial myocytes, and to uncover the mechanism underlying the treatment of fibrillation (AF) by AT 1 R blockers. Methods: Hyposmotic solution (Hypo-S) was applied in the guinea pig atrial myocytes to simulate cell stretch, then patch-clamp technique was applied to record the I Ks and APD in atrial myocytes. Results: Hypo-S increased the I Ks by 105.6%, while Hypo-S+1-20 μM of losartan only increased the I Ks by 70.3-75.5% (p<0.05 vs. Hypo-S). Meanwhile, Hypo-S shortened APD 90 by 20.2%, while Hypo-S+1-20 μM of losartan shortened APD 90 by 13.03-14.56% (p<0.05 vs. Hypo-S).
Conclusion:The above data indicate that the effect of losartan on the electrophysiological changes induced by stretch of atrial myocytes is associated with blocking of AT 1 receptor, and is beneficial for the treatment of AF that is often accompanied by the expansion of atrial myocytes and the increase of effective refractory period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.